United Therapeutics | UTHR - Operating Profit


United Therapeutics reported $241.3M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Amarin USD -2.26M 564K Dec/2025
Ardelyx USD -12.42M 20.37M Jun/2026
Baxter International USD 314M 38M Sep/2026
Bayer EUR 129M 698M Sep/2026
BioCryst Pharmaceuticals USD 98.46M 161.92M Jun/2026
Biogen USD 419.5M 663.3M Sep/2026
BioMarin Pharmaceutical USD 205.6M 100M Sep/2026
Emergent BioSolutions USD -218M 69.9M Jun/2023
Gilead Sciences USD 3.85B 1.17B Jun/2026
GlaxoSmithKline GBP 2.86B 251M Sep/2026
Halozyme Therapeutics USD -60.68M 3.04M Sep/2026
Insmed USD -81.83M 19.48M Sep/2026
Ionis Pharmaceuticals USD -130M 27.71M Sep/2026
J&J USD 6.47B 1B Sep/2026
Lexicon Pharmaceuticals USD -14.78M 2.59M Dec/2025
Moderna USD 130M 945M Sep/2026
Omeros USD -35.41M 23.75M Sep/2024
Pfizer USD 662M 5M Sep/2026
PTC Therapeutics USD 148.98M 103.09M Jun/2026
Regeneron Pharmaceuticals USD 1.42B 675.7M Jun/2026
Sangamo BioSciences USD -33.51M 12.77M Jun/2024
Sarepta Therapeutics USD -9.04M 22.33M Sep/2026
Teva Pharmaceutical Industries USD 1.19B 954M Sep/2026
United Therapeutics USD 241.3M 89.5M Sep/2026
Vertex Pharmaceuticals USD 1.26B 11.3M Sep/2026